Cancer BiologybioRxivPreprint
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomas
Heba A. Ali, Ningjia Zhou, Li Chen…·Crismita Dmello
This study identifies the CHK2-YBX1&YBX3 hub as an immunosuppressive mechanism in gliomas and shows that targeting it with SU056 enhances immune checkpoint blockade efficacy.
2 citations